- Capital Cube•2 days ago
Click here to see latest analysis*Disclaimer : This is as of previous day’s closeETF’s with exposure to Psychemedics Corp.Here are 5 ETF’s with the largest exposure to PMD-US. Comparing the performance and risk of Psychemedics Corp. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns […] (Read more...) The post ETF’s with exposure to Psychemedics Corp. : July 21, 2016 appeared first on CapitalCube.
- Capital Cube•3 months ago
Click here to see latest analysisPsychemedics Corp. reports financial results for the quarter ended March 31, 2016.We analyze the earnings along side the following peers of Psychemedics Corp. – NeoGenomics, Inc., Enzo Biochem, Inc. and Quest Diagnostics Incorporated (NEO-US, ENZ-US and DGX-US) that have also reported for this period.HighlightsSummary numbers: Revenues of USD 6.67 million, […] (Read more...) The post Psychemedics Corp. :PMD-US: Earnings Analysis: Q1, 2016 By the Numbers appeared first on CapitalCube.
|Ask||14.90 x 100|
|52wk Range||7.76 - 14.97|
|Day's Range||13.85 - 14.42|
|Avg Vol (3m)||10,792|
As of 4:00 PM EDT. Market closed.